JNJ to Acquire Halda Therapeutics for $3.05 Billion to Boost Oncology Pipeline
JNJ to Acquire Halda Therapeutics for $3.05 Billion to Boost Oncology Pipeline Vardah Gill Mon, December 1, 2025 at 3:01 AM GMT+8 2 min read In this article: JNJ -0.31% ITCI Johnson & Johnson (NYSE:JN...